Diabetikere, der anvender lægemidlet, har risiko for hypoglykæmi (lavt blodsukker), hvorfor disses behandling med antidiabetikum skal justeres.
Diabetic patients using the medicine have a risk of hypoglycaemia (low blood sugar), and their antidiabetes treatment may need to be adjusted.